AnalyzeDirect Seshadri M, Bellnier DA. The vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid improves the antitumor efficacy and shortens treatment time associated with Photochlor-sensitized photodynamic therapy in vivo. Photochem Photobiol. January 2009;85(1):50-56.
Full Text – Open Access
Publication Date
January 2009
How Analyze was Used
“Image processing and analysis was carried out using commercially available software (Analyze PC, Version 7.0; AnalyzeDirect, Overland Park, KS).”
Keywords
Animals
Antineoplastic Agents/therapeutic use
Cell Line, Tumor
Chlorophyll/analogs & derivatives/therapeutic use
Drug Combinations
Interleukin-6/metabolism
Magnetic Resonance Imaging (MRI)
Mice
Mice, Inbred BALB C
Neoplasm Transplantation
Neoplasms/blood supply/drug therapy/pathology
Neovascularization, Pathologic/drug therapy
Photochemotherapy
Photosensitizing Agents/therapeutic use
Time Factors
Tumor Necrosis Factor-alpha/metabolism
Xanthones/therapeutic use
Author Affiliation(s)
Photodynamic Therapy Center (Department of Cell Stress Biology), Roswell Park Cancer Institute, Buffalo, NY, US. (MS, DAB)
Preclinical Imaging Resource (Department of Cancer Biology), Roswell Park Cancer Institute, Buffalo, NY, US. (MS)
ID# 1340
Tags: Animals, Antineoplastic Agents/therapeutic use, Chlorophyll/analogs & derivatives/therapeutic use, Drug Combinations, Inbred BALB C Mice, Interleukin-6/metabolism, Magnetic Resonance Imaging (MRI), Mice, Neoplasm Transplantation, Neoplasms/blood supply/drug therapy/pathology, Pathologic Neovascularization/drug therapy, Photochemotherapy, Photosensitizing Agents/therapeutic use, Time Factors, Tumor Cell Line, Tumor Necrosis Factor-alpha/metabolism, Xanthones/therapeutic use